Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 13.50
-0.05 (-0.37%)
Apr 17, 2026, 2:13 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 9.13 billion as of April 16, 2026. Its market cap has increased by 84.97% in one year.
Market Cap
9.13B
Enterprise Value
6.80B
Revenue
681.17M
Ranking
n/a
PE Ratio
137.68
Stock Price
13.50
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 9.13B, an increase of 4.78%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 9.13B | 4.34% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 14.05B |
| CARsgen Therapeutics Holdings | 12.93B |
| HBM Holdings | 12.36B |
| Lepu Biopharma | 11.75B |
| Alphamab Oncology | 11.61B |
| Guangzhou Innogen Pharmaceutical Group | 9.55B |
| Shanghai Haohai Biological Technology | 9.34B |
| Laekna | 7.36B |